Literature DB >> 29393460

LPS‑induced proinflammatory cytokine expression in human airway epithelial cells and macrophages via NF‑κB, STAT3 or AP‑1 activation.

Xuefang Liu1, Sugai Yin1, Yulong Chen1, Yaosong Wu1, Wanchun Zheng1, Haoran Dong1, Yan Bai1, Yanqin Qin1, Jiansheng Li1, Suxiang Feng1, Peng Zhao1.   

Abstract

Lipopolysaccharide (LPS), the major outer surface membrane component of Gram-negative bacteria, is one of the main etiological factors in the pathogenesis of several lung diseases, such as chronic obstructive pulmonary disease. The respiratory epithelium and the macrophages comprise the dynamic interface between the outside environment and the host response to bacterial infection via cytokine secretion. In the present study, the mechanisms of LPS induced‑inflammatory response in human lung cells and macrophages were investigated. The effects of LPS exposure on cytokine production, inflammation‑related transcription factors and intracellular signaling pathway activation were assessed in human lung mucoepidermoid carcinoma H292 cells and human macrophage THP‑1 cells. The results demonstrated that LPS markedly increased the expression of interleukin (IL)‑6, IL‑8, tumor necrosis factor (TNF)‑α, matrix metallopeptidase (MMP)‑9 and tissue inhibitor of metalloproteinases‑1 in H292 cells, while it increased the production of IL‑6, IL‑8 and TNF‑α in differentiated THP‑1 cells. In addition, LPS exposure activated nuclear factor (NF)‑κB and activator protein (AP)‑1 signaling in H292 cells, while it activated NF‑κB and signal transducer and activator of transcription (STAT) 3 signaling in THP‑1 cells. Furthermore, treatment with NF‑κB, AP‑1 or STAT3 inhibitors significantly decreased the LPS‑mediated expression of IL‑8 and TNF‑α in these cells, suggesting that these pathways might serve crucial roles in LPS‑induced cytokine expression. In conclusion, LPS stimulation of H292 and THP‑1 cells induced cytokine expression and NF‑κB, mitogen‑activated protein kinase and Janus kinase/STAT3 pathway activation with subsequent nuclear translocation of NF‑κB, AP‑1 and STAT3, which demonstrated potential of the use of NF‑κB, AP‑1 and STAT3 in therapies for conditions and diseases associated with chronic inflammation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29393460     DOI: 10.3892/mmr.2018.8542

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  35 in total

1.  Low Vitamin D Status Is Associated with Inflammation in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Lin Fu; Jun Fei; Zhu-Xia Tan; Yuan-Hua Chen; Biao Hu; Hui-Xiang Xiang; Hui Zhao; De-Xiang Xu
Journal:  J Immunol       Date:  2020-12-23       Impact factor: 5.422

2.  Protective effects of ginsenoside-Rg2 and -Rh1 on liver function through inhibiting TAK1 and STAT3-mediated inflammatory activity and Nrf2/ARE-mediated antioxidant signaling pathway.

Authors:  Thuy Le Lam Nguyen; Diem Thi Ngoc Huynh; Yujin Jin; Hyesu Jeon; Kyung-Sun Heo
Journal:  Arch Pharm Res       Date:  2021-02-03       Impact factor: 4.946

3.  Recombinant human β-defensin130 inhibited the growth of foodborne bacteria through membrane disruption and exerted anti-inflammatory activity.

Authors:  Bin Dong; Yanjun Lin; Zhiwei Su; Chunlong Sun; Jun Wang; Shijun Fu; Wen Du; Tao Wu
Journal:  Food Sci Biotechnol       Date:  2022-04-20       Impact factor: 3.231

4.  IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer's disease mouse model.

Authors:  Niklas Lonnemann; Shirin Hosseini; Melanie Ohm; Robert Geffers; Karsten Hiller; Charles A Dinarello; Martin Korte
Journal:  Elife       Date:  2022-08-30       Impact factor: 8.713

5.  Anti-Inflammatory Effects of Cicadidae Periostracum Extract and Oleic Acid through Inhibiting Inflammatory Chemokines Using PCR Arrays in LPS-Induced Lung inflammation In Vitro.

Authors:  Jung-Hee Hong; Young-Cheol Lee
Journal:  Life (Basel)       Date:  2022-06-08

Review 6.  Recent advances in dead cell clearance during acute lung injury and repair.

Authors:  Patrick M Noone; Sekhar P Reddy
Journal:  Fac Rev       Date:  2021-03-30

7.  Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway.

Authors:  Tao Pan; Fang Zhang; Fakai Li; Xingchun Gao; Zhikui Li; Xia Li; Xinling Ren
Journal:  Oncol Rep       Date:  2020-07-09       Impact factor: 3.906

8.  Suppression of LPS-Induced Inflammation by Chalcone Flavokawain A through Activation of Nrf2/ARE-Mediated Antioxidant Genes and Inhibition of ROS/NFκB Signaling Pathways in Primary Splenocytes.

Authors:  Hsin-Ling Yang; Ting-Yu Yang; Yugandhar Vudhya Gowrisankar; Chun-Huei Liao; Jiunn-Wang Liao; Pei-Jane Huang; You-Cheng Hseu
Journal:  Oxid Med Cell Longev       Date:  2020-06-12       Impact factor: 6.543

Review 9.  TIRAP in the Mechanism of Inflammation.

Authors:  Sajjan Rajpoot; Kishore K Wary; Rachel Ibbott; Dongfang Liu; Uzma Saqib; Teresa L M Thurston; Mirza S Baig
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

10.  Ranunculus bulumei Methanol Extract Exerts Anti-Inflammatory Activity by Targeting Src/Syk in NF-κB Signaling.

Authors:  Yo Han Hong; Ji Hye Kim; Jae Youl Cho
Journal:  Biomolecules       Date:  2020-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.